Leslie Marie Greenlee, DO | |
855 A Ave Ne, Cedar Rapids, IA 52402-5057 | |
(319) 368-9301 | |
Not Available |
Full Name | Leslie Marie Greenlee |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 855 A Ave Ne, Cedar Rapids, Iowa |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700105780 | NPI | - | NPPES |
1700105780 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 4417 (Iowa) | Primary |
Entity Name | Iowa Physicians Clinic Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare.
Alexion Pharmaceuticals, Inc. joins the European Organization for Rare Diseases, the National Organization for Rare Disorders and families, governments, companies and medical communities around the world in observing the fourth annual Rare Disease Day today.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 6 days ago
Entity Name | St Lukes Methodist Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073553939 PECOS PAC ID: 6608786751 Enrollment ID: O20040204000942 |
News Archive
A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare.
Alexion Pharmaceuticals, Inc. joins the European Organization for Rare Diseases, the National Organization for Rare Disorders and families, governments, companies and medical communities around the world in observing the fourth annual Rare Disease Day today.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Leslie Marie Greenlee, DO 855 A Ave Ne, Cedar Rapids, IA 52402-5057 Ph: (319) 431-8011 | Leslie Marie Greenlee, DO 855 A Ave Ne, Cedar Rapids, IA 52402-5057 Ph: (319) 368-9301 |
News Archive
A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare.
Alexion Pharmaceuticals, Inc. joins the European Organization for Rare Diseases, the National Organization for Rare Disorders and families, governments, companies and medical communities around the world in observing the fourth annual Rare Disease Day today.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 6 days ago
Dr. Kathryn Lorraine Kaufman, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 855 A Ave Ne Ste 300, Cedar Rapids, IA 52402 Phone: 319-368-9301 Fax: 319-368-5690 | |
Staci L Wedel, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 855 A Ave Ne, Suite 300, Cedar Rapids, IA 52402 Phone: 319-368-9300 Fax: 319-368-5690 | |
Haley Plath, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-861-7900 | |
Nhan-ai Truong, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7247 Fax: 319-368-5973 | |
Erin Swieter, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7211 | |
Dr. Dinah M Conti, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 855 A Ave Ne Ste 300, Unity Point Clinics Cedar Rapids - Pediatrics, Cedar Rapids, IA 52402 Phone: 319-368-9300 Fax: 319-368-5690 | |
Dr. Bethany G Vargas, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 411 10th St Se Ste 150, Cedar Rapids, IA 52403 Phone: 319-363-3600 Fax: 319-678-7399 |